PixCell Medical
Shmuel Cabilly, Ph.D., is a leading scientist and inventor in the field of immunology. His patented inventions related to recombinant antibody production have led to the development of widely used drugs, such as Herceptin, Rituxan, Avestin, and others. Dr. Cabilly was the co-founder and chief scientist of Ethrog Biotechnology, where he invented dry buffer technologies that enable the production of a disposable apparatus for gel electrophoresis containing no liquid and technology that enables the condensation of molecule separation zones to a small gel area. Dr. Cabilly holds a Ph.D. in Immunology from the Hebrew University in Jerusalem.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
PixCell Medical
3 followers
PixCell Medical provides the first truly portable point-of-care blood diagnostic solution. Leveraging the company’s patented Viscoelastic Focusing technology, along with AI-powered machine vision, PixCell’s FDA-cleared and CE-cleared HemoScreen diagnostic platform shortens diagnostic results delivery from days to minutes. With just one drop of blood and within five minutes, PixCell delivers accurate readings of 20 standard blood count parameters, saving patients, clinicians and health systems significant time and costs.